Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PVLA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
38 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 26 days ago
Red flags: 5
197 filers reported a long position in PVLA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173.5M | 1.1M | -1.6% |
| JENNISON ASSOCIATES LLC | $146.8M | 960.6K | +50% |
| BlackRock, Inc. | $140.3M | 918.4K | +33.7% |
| Frazier Life Sciences Management, L.P. | $134.8M | 882.4K | Unchanged |
| First Light Asset Management, LLC | $118M | 771.9K | -21.3% |
| BVF INC/IL | $102.8M | 672.8K | -30% |
| STATE STREET CORP | $99.8M | 653.2K | +42.3% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $97.6M | 638.9K | +58.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $78.5M | 513.8K | +7.6% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73.2M | 478.8K | +28% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.